NASDAQ · Biotechnology

YD Bio Limited Ordinary Shares (YDES) Stock

$2.23 -0.45% NASDAQ: YDES Healthcare

Breeze Holdings Acquisition Corp. is a clinical-stage biopharmaceutical company based in Taipei, Taiwan.

Valuation

MetricValue
Price$2.23
Market Cap$157.95M
P/E Ratio-1.37
P/B Ratio-2.67
P/S Ratio158.66
EPS (TTM)$-0.12
52-Week High$25.00
52-Week Low$1.70
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE52.09%
ROA-40.51%
ROCE-6.12%
Gross Margin-500.00%
Operating Margin-500.00%
Net Margin-800.00%
Debt/Equity0.00
Current Ratio5.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$1.0M$1.0M
Operating Profit$-2.0M$-2.0M$0$-1.0M$-5.0M
Net Profit$9.0M$4.0M$0$-1.0M$-8.0M
EPS$0.59$0.41$0.00$-0.56$-0.12
Op Margin——-2.8%-286.4%-883.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$118.0M$18.0M$0$7.0M$14.0M
Total Liabilities$9.0M$7.0M$0$0$17.0M
Cash$0$0$0$3.0M$6.0M
Borrowings$0$0$0$0$0

Latest News

YD Bio Expands U.S. Laboratory Footprint to 46 States, Strengthening DNA-Methylation Early Cancer Detection Operations GlobeNewswire · Jul 2, 2026 YD Bio Limited Reports Full Year 2025 Financial Results GlobeNewswire · Apr 30, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-1.0M$-3.0M$0$-2.0M$-7.0M
Investing Cash Flow$-1.0M$100.0M$0$-6.0M$-3.0M
Financing Cash Flow$0$-102.0M$0$0$0
Net Cash Flow$-1.0M$0$0$3.0M$3.0M
Free Cash Flow$-1.0M$-3.0M$0$-5.0M$-8.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-27.98
FCF Yield-5.06%
Quick Ratio4.00
Interest Coverage0.00
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Insiders Held80.13%
Institutions Held0.23%
Institutions Float Held1.13%
Institutional HolderSharesReport Date
Geode Capital Management, LLC60,2362026-03-31
Cerity Partners LLC32,4062026-03-31
Cypress Capital Management, LLC (WY)30,6902026-03-31
Citadel Advisors Llc19,4502026-03-31
UBS Group AG11,6282026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BTXBlackRock Innovation and Growth Term Trust $8.58 +0.00% 0.00 $1.00B 8.21%
DAWNDay One Biopharmaceuticals, Inc. $21.53 +0.00% -20.70 $2.22B 0.00%
GERN $1.34 -4.29% 23.17 $859.64M 0.00%
GLUE $22.56 -0.97% -40.87 $1.91B 0.00%
LENZ $5.05 +1.10% -3.18 $158.34M 0.00%

About YD Bio Limited Ordinary Shares

Breeze Holdings Acquisition Corp. is a clinical-stage biopharmaceutical company based in Taipei, Taiwan. The firm concentrates its efforts on developing medical diagnostics for cancer prevention and creating exosome-based therapeutics, both of which aim to revolutionize treatment options for diseases with significant unmet medical needs.

YD Bio Limited Ordinary Shares is led by CEO Ethan Shen, publicly traded since 2025.

YD Bio Limited Ordinary Shares (YDES) stock trades at $2.23 with a market capitalization of $157.95M. The stock is valued at a price-to-earnings (P/E) ratio of -1.37, price-to-book of -2.67, price-to-sales of 158.66. Over the past 52 weeks the stock has ranged between $1.70 and $25.00, and currently trades 91.1% below its 52-week high.

On profitability, YD Bio Limited Ordinary Shares generates a return on equity (ROE) of 52.09% — well above the market average, a sign of a high-quality business, return on capital employed of -6.12%, an operating margin of -500.00%, a net profit margin of -800.00%.

Official website: www.ydesgroup.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides